Dopa-responsive hypersomnia and mixed movement disorder due to sepiapterin reductase deficiency
- 12 December 2006
- journal article
- case report
- Published by Wolters Kluwer Health in Neurology
- Vol. 67 (11) , 2032-2035
- https://doi.org/10.1212/01.wnl.0000247274.21261.b4
Abstract
Sepiapterin reductase deficiency (SRD) is a rare, treatable disorder of monoamine metabolism with cognitive delay and l-dopa responsive movement disorder. We describe a patient with SRD and distinctive phenotypic feature of marked hypersomnolence. Our patient showed improvement with therapies directed at both serotonergic and dopaminergic deficiencies. This case illustrates symptoms that characterize the SRD phenotype and demonstrates the importance of systematic treatment trials addressing the various biochemical abnormalities present.Keywords
This publication has 7 references indexed in Scilit:
- Sepiapterin reductase deficiency: a congenital dopa-responsive motor and cognitive disorderBrain, 2005
- Heterozygous mutation in 5?-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonianeurogenetics, 2004
- Selective Decrease in Central Nervous System Serotonin Turnover in Children with Dopa-Nonresponsive DystoniaPediatric Research, 2002
- Reduced nitric oxide metabolites in CSF of patients with tetrahydrobiopterin deficiencyJournal of Neurochemistry, 2002
- Sepiapterin Reductase Deficiency: Molecular Analysis in a New Case Presenting with Neurotransmitter Deficiency without HyperphenylalaninemiaPublished by Springer Nature ,2002
- Mutations in the Sepiapterin Reductase Gene Cause a Novel Tetrahydrobiopterin-Dependent Monoamine-Neurotransmitter Deficiency without HyperphenylalaninemiaAmerican Journal of Human Genetics, 2001
- Variant of dihydropteridine reductase deficiency without hyperphenylalaninaemia: Effect of oral phenylalanine loadingJournal of Inherited Metabolic Disease, 1999